doi:10.4103/ijdd.ijdd 6. Lipke MM. An armamentarium of wart treatments. Clin Med Res . 2006;4(4):273 -293. doi:10.3121/cmr.4.4.273 7. Salman S, Ahmed MS, Ibrahim AM, Mattar OM, El -Shirbiny H, Sarsik S, Afifi AM, Anis RM, Yakoub Agha NA, Abushouk AI. Intralesional immunotherapy for the tr eatment of warts: A network meta -analysis. J Am Acad Dermatol. 2019 Apr;80(4):922 -930.e4. doi: 10.101. doi:10.1016/j.jaad.2018.07.003 8. Nofal A, Nofal E, Yosef A, Nofal H. Treatment of recalcitrant warts with 28 intralesional measles, mumps, and rubella vac cine: A promising approach. Int J Dermatol . 2015;54(6):667 -671. doi:10.1111/ijd.12480 9. Leung L. Recalcitrant nongenital warts. Aust Fam Physician . 2011;40(1 - 2):40 -42. 10. Thappa DM, Chiramel MJ. Evolving role of immunotherapy in the treatment of refrac tory warts. Indian Dermatol Online J. 2016 Sep - Oct;7(5):364 -370. Review. PubMed 27730031. doi:10.4103/2229 -5178.190487 11. Goihman -Yahr M, Goldblum OM. Immunotherapy and warts: a point of view. Clin Dermatol . 2008;26(2):223 -225. doi:10.1016/j.clindermato l.2007.10.011 12. Kareem IMA, Ibrahim IM, Mohammed SFF, Ahmed AA. Effectiveness of intralesional vitamin D 3 injection in the treatment of common warts: Single blinded placebo controlled study . Dermatol Ther . Published online 2019:e12882. doi:10.1111/dt h.12882 13. Nofal A, Salah E, Nofal E, Yosef A. Intralesional antigen immunotherapy for the treatment of warts: Current concepts and future prospects. Am J Clin Dermatol . 2013;14(4):253 -260. doi:10.1007/s40257 -013-0018 -8 14. Abd-Elazeim FMA, Mohammed GFA , Fathy A, Mohamed RW. Evaluation of IL-12 serum level in patients with recalcitrant multiple common warts, treated by intralesional tuberculin antigen. J Dermatolog Treat . 2014;25(3):264 -267. doi:10.3109/09546634.2013.768760 15. Horn TD, Johnson SM, Helm RM, Roberson PK. Intralesional immunotherapy of warts with mumps, Candida, and Trichophyton skin test antigens: a single -blinded, randomized, and controlled trial. Arch Dermatol.